Truist raised the firm’s price target on Seagen to $152 from $135 and keeps a Hold rating on the shares. The company’s Q4 results were "good" and the stock is rising on its 2023 outlook, reflecting the management’s belief that underlying product sales are trending favorably while leaving room for continued quarterly beats, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SGEN:
- Seagen price target raised to $168 from $142 at JMP Securities
- Seagen price target raised to $155 from $145 at RBC Capital
- Seagen upgraded to Outperform from In Line at Evercore ISI
- Seagen upgraded to Strong Buy from Outperform at Raymond James
- Seagen sees FY23 revenue $2.14B-$2.24B, consensus $2.3B